Farnaz Hasteh

1.6k total citations
53 papers, 937 citations indexed

About

Farnaz Hasteh is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Farnaz Hasteh has authored 53 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 15 papers in Oncology and 14 papers in Surgery. Recurrent topics in Farnaz Hasteh's work include Cancer Genomics and Diagnostics (11 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (8 papers). Farnaz Hasteh is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (8 papers). Farnaz Hasteh collaborates with scholars based in United States, Germany and Thailand. Farnaz Hasteh's co-authors include Jeanette D. Cheng, Volkan Adsay, Noel Weidner, James S. Neill, Syed Akbar, Syed Jafri, Claire W. Michael, Grace Lin, Oluwole Fadare and Ds Klimstra and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Farnaz Hasteh

52 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farnaz Hasteh United States 16 469 377 232 160 135 53 937
Renato Covello Italy 20 253 0.5× 245 0.6× 193 0.8× 88 0.6× 237 1.8× 79 1.0k
James Conner Canada 15 237 0.5× 282 0.7× 230 1.0× 95 0.6× 87 0.6× 50 766
Francesca Maletta Italy 20 301 0.6× 317 0.8× 118 0.5× 49 0.3× 169 1.3× 63 1.0k
Sun Hee Chang South Korea 16 298 0.6× 215 0.6× 319 1.4× 72 0.5× 101 0.7× 74 786
Shyam K. Shrivastava India 16 328 0.7× 217 0.6× 228 1.0× 84 0.5× 137 1.0× 31 918
John D. Coyne United Kingdom 21 245 0.5× 326 0.9× 314 1.4× 302 1.9× 142 1.1× 75 1.1k
Takuma Tajiri Japan 20 694 1.5× 869 2.3× 373 1.6× 121 0.8× 133 1.0× 92 1.4k
Yasuharu Kaizaki Japan 18 553 1.2× 428 1.1× 472 2.0× 72 0.5× 83 0.6× 61 1.1k
Douglas W. Franquemont United States 15 596 1.3× 254 0.7× 467 2.0× 138 0.9× 172 1.3× 20 1.3k
Ken Kikuchi Japan 16 350 0.7× 420 1.1× 176 0.8× 71 0.4× 50 0.4× 35 971

Countries citing papers authored by Farnaz Hasteh

Since Specialization
Citations

This map shows the geographic impact of Farnaz Hasteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farnaz Hasteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farnaz Hasteh more than expected).

Fields of papers citing papers by Farnaz Hasteh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farnaz Hasteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farnaz Hasteh. The network helps show where Farnaz Hasteh may publish in the future.

Co-authorship network of co-authors of Farnaz Hasteh

This figure shows the co-authorship network connecting the top 25 collaborators of Farnaz Hasteh. A scholar is included among the top collaborators of Farnaz Hasteh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farnaz Hasteh. Farnaz Hasteh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatami, Elham, et al.. (2025). 162 HER2-ultra low and HER2-null Breast Cancers, Incidence and Correlation with Clinicopathologic Parameters. Laboratory Investigation. 105(3). 102386–102386. 1 indexed citations
3.
Pineda, Jaime A., et al.. (2024). Diagnostic modalities in the mediastinum and the role of bronchoscopy in mediastinal assessment: a narrative review. Mediastinum. 8. 51–51. 1 indexed citations
4.
Bykowski, Julie, Kevin T. Brumund, Vera Vavinskaya, et al.. (2022). B3 thymoma mimicking poorly differentiated thyroid carcinoma: Diagnostic pitfalls of anterior mediastinal mass fine needle aspiration. Diagnostic Cytopathology. 51(2). E75–E81. 1 indexed citations
5.
Nachmanson, Daniela, Adam Officer, Hidetoshi Mori, et al.. (2022). The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ. npj Breast Cancer. 8(1). 6–6. 9 indexed citations
6.
Fadare, Oluwole, et al.. (2021). Nonmass enhancement lesions of the breast on core needle biopsy: outcomes, frequency of malignancy, and pathologic findings. Human Pathology. 111. 92–97. 5 indexed citations
7.
Hu, Jingjing, et al.. (2021). Rectal endometriosis mimicking primary rectal adenocarcinoma. Diagnostic Cytopathology. 49(12). E437–E442. 2 indexed citations
8.
Havenar‐Daughton, Colin, et al.. (2020). Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations. Journal of Immunological Methods. 479. 112746–112746. 26 indexed citations
9.
Hu, Jingjing, et al.. (2019). Intranodal palisaded myofibroblastoma of para‐esophageal lymph node: Case report with cytologic and histologic findings. Diagnostic Cytopathology. 47(12). 1306–1309. 1 indexed citations
11.
12.
Solomon, James P., Marie L. Dell’Aquila, Oluwole Fadare, & Farnaz Hasteh. (2016). Her2/neu Status Determination in Breast Cancer. American Journal of Clinical Pathology. 147(4). 432–437. 31 indexed citations
13.
Engelberg, Jesse A., Hanna Retallack, Ronald Balassanian, et al.. (2015). “Score the Core” Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring. Human Pathology. 46(11). 1694–1704. 11 indexed citations
14.
Hasteh, Farnaz, et al.. (2012). Atypical Ductal Hyperplasia at the Margin of Lumpectomy Performed for Early Stage Breast Cancer: Is there Enough Evidence to Formulate Guidelines?. International Journal of Surgical Oncology. 2012. 1–5. 9 indexed citations
15.
Bao, Lirong, Minya Pu, Brian Crain, et al.. (2012). Abstract P2-06-01: Breast-to-breast metastasis can cause hormone-receptor positive/triple negative bilateral synchronous tumors. Cancer Research. 72(24_Supplement). P2–6. 1 indexed citations
16.
Lin, Grace, et al.. (2012). The Clinical Significance of “Squamous Intraepithelial Lesion of Indeterminate Grade” as a Distinct Cytologic Category. American Journal of Clinical Pathology. 137(5). 753–760. 1 indexed citations
17.
Kerber, Charles W., et al.. (2011). 1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new berry aneurysm treatment. II. Rabbit implant studies: technique and histology. Journal of NeuroInterventional Surgery. 4(1). 50–57. 3 indexed citations
18.
Hasteh, Farnaz, Grace Lin, Noel Weidner, & Claire W. Michael. (2010). The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathology. 118(2). 90–96. 97 indexed citations
19.
Hasteh, Farnaz, Robert T. Pu, & Claire W. Michael. (2007). A metastatic renal carcinoid tumor presenting as breast mass: A diagnostic dilemma. Diagnostic Cytopathology. 35(5). 306–310. 13 indexed citations
20.
Adsay, Volkan, Farnaz Hasteh, Jeanette D. Cheng, & Ds Klimstra. (2000). Squamous-lined cysts of the pancreas: lymphoepithelial cysts, dermoid cysts (teratomas), and accessory-splenic epidermoid cysts.. PubMed. 17(1). 56–65. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026